Discovery of Ketamine applications to clinical psychiatry
Published by Reblogs - Credits in Posts,
The discovery of ketamine's psychiatric effects indeed marked a significant shift in the field of neuropsychopharmacology. Let's delve into the origins and scientific evidence behind this fascinating phenomenon.
1. Initial Development and Safety Profile:
- Ketamine, a non-competitive N-methyl-D-aspartate receptor (NMDAR) antagonist, was initially developed in 1962 as a shorter-acting sedative agent to replace phencyclidine (PCP).
- Due to its broad safety profile, ketamine quickly gained widespread use ¹.
- Beyond its sedative properties, evidence suggested that ketamine might possess neuroprotective, anti-inflammatory effects, and could decrease hyperalgesia while preventing septic and hypovolemic shock ¹.
2. Interest in Antidepressant Effects:
- The investigation of another NMDAR antagonist, MK-801, as a putative antidepressant in the early 1990s sparked interest in the potential antidepressant effects of glutamatergic modulation ¹.
- However, the discovery of ketamine's rapid-acting antidepressant actions was not serendipitous; it was based on significant preclinical research.
- A seminal clinical study conducted by Berman and colleagues in 2000 demonstrated that a subanesthetic dose of ketamine alleviated depressive symptoms within hours—a feat previously unheard of for the treatment of any neuropsychiatric disorder ¹.
3. Clinical Research and Mechanisms:
- Subsequent clinical research supported the use of subanesthetic-dose ketamine (and its enantiomer esketamine) in multiple neuropsychiatric disorders, including depression, bipolar disorder, anxiety spectrum disorders, substance use disorders, eating disorders, and chronic pain management.
- Ketamine effectively targeted symptom domains associated with various disorders, such as anxiety, anhedonia, and suicidal ideation ¹.
- Mechanistically, ketamine's antidepressant efficacy involves complex interactions with glutamatergic pathways, including its (S)- and (R)-enantiomers, as well as its hydroxynorketamine (HNK) metabolite ¹.
4. Ongoing Research and Insights:
- Ongoing studies continue to explore ketamine's effects on cognition, anxiety, quality of life, and social functioning in adults with psychiatric disorders ³.
- Systematic reviews and meta-analyses provide robust evidence for rapid and transient antidepressant and anti-suicidal effects of ketamine ².
- However, caution is necessary due to the high risk of bias in some included studies ².
In summary, ketamine's journey from an anesthetic agent to a groundbreaking neuropsychiatric therapeutic underscores the importance of rigorous research and clinical investigation. Its unique mechanisms of action continue to captivate researchers and offer hope for patients experiencing treatment-resistant depression and related conditions ¹²..
Source: Conversation with Bing, 4/5/2024
(1) Ketamine in neuropsychiatric disorders: an update - Nature. https://www.nature.com/articles/s41386-023-01632-1.pdf.
(2) The effect of ketamine on cognition, anxiety, and social functioning in .... https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730521/.
(3) Ketamine for the treatment of mental health and substance use disorders .... https://www.cambridge.org/core/journals/bjpsych-open/article/ketamine-for-the-treatment-of-mental-health-and-substance-use-disorders-comprehensive-systematic-review/36E261BFA62CDA6459B88F7777415FDA.
(4) New Study Maps Ketamine's Effects on Brain | Columbia News. https://news.columbia.edu/news/new-study-maps-ketamines-effects-brain.
(5) undefined. https://doi.org/10.1038/s41386-023-01632-1.